SOICHIRO TODA

800 total citations
27 papers, 604 citations indexed

About

SOICHIRO TODA is a scholar working on Pharmacology, Molecular Biology and Organic Chemistry. According to data from OpenAlex, SOICHIRO TODA has authored 27 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 11 papers in Molecular Biology and 8 papers in Organic Chemistry. Recurrent topics in SOICHIRO TODA's work include Microbial Natural Products and Biosynthesis (14 papers), Cancer therapeutics and mechanisms (4 papers) and Peptidase Inhibition and Analysis (3 papers). SOICHIRO TODA is often cited by papers focused on Microbial Natural Products and Biosynthesis (14 papers), Cancer therapeutics and mechanisms (4 papers) and Peptidase Inhibition and Analysis (3 papers). SOICHIRO TODA collaborates with scholars based in United Kingdom, Germany and Japan. SOICHIRO TODA's co-authors include TOSHIKAZU OKI, MASATAKA KONISHI, Koko Sugawara, Yuji Nishiyama, Susumu Nakagawa, Haruaki Yamamoto, Minoru Hanada, Koji Tomita, TAKAYUKI NAITÔ and Hiroshi Kawaguchi and has published in prestigious journals such as Tetrahedron Letters, Clinica Chimica Acta and The Journal of Antibiotics.

In The Last Decade

SOICHIRO TODA

27 papers receiving 566 citations

Peers

Countries citing papers authored by SOICHIRO TODA

Since Specialization

Citations

This map shows the geographic impact of SOICHIRO TODA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SOICHIRO TODA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SOICHIRO TODA more than expected).

Fields of papers citing papers by SOICHIRO TODA

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SOICHIRO TODA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SOICHIRO TODA. The network helps show where SOICHIRO TODA may publish in the future.

Co-authorship network of co-authors of SOICHIRO TODA

This figure shows the co-authorship network connecting the top 25 collaborators of SOICHIRO TODA. A scholar is included among the top collaborators of SOICHIRO TODA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SOICHIRO TODA. SOICHIRO TODA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vitamin B6 in acute encephalopathy with biphasic seizures and late reduced diffusion 2020 ·Brain and Development ·Tomoyuki Akiyama, SOICHIRO TODA, (unknown), Yukiko Mogami, (unknown), (unknown), (unknown), (unknown), (unknown), Katsuhiro Kobayashi	6
2	Determination of CSF 5-methyltetrahydrofolate in children and its application for defects of folate transport and metabolism 2016 ·Clinica Chimica Acta ·Mari Akiyama, Tomoyuki Akiyama, (unknown), (unknown), Hiroko Tada, (unknown), SOICHIRO TODA, Katsumi Imai, Yu Kobayashi, Jun Tohyama, (unknown), Harumi Yoshinaga, Katsuhiro Kobayashi	6
3	Measurement of pyridoxal 5′-phosphate, pyridoxal, and 4-pyridoxic acid in the cerebrospinal fluid of children 2016 ·Clinica Chimica Acta ·Tomoyuki Akiyama, Mari Akiyama, Yumiko Hayashi, Takashi Shibata, (unknown), SOICHIRO TODA, Katsumi Imai, Shin-ichiro Hamano, Tohru Okanishi, Harumi Yoshinaga, Katsuhiro Kobayashi	15
4	Efficacy and safety of fosphenytoin for benign convulsions with mild gastroenteritis 2015 ·Brain and Development ·(unknown), SOICHIRO TODA, Shinpei Abe, Mitsuru Ikeno, (unknown), (unknown), (unknown), Shinichi Niijima, Toshiaki Shimizu, Akihisa Okumura	16
5	Mevalonic acidemia: First case of Japan 1997 ·The Japanese Journal of Human Genetics ·(unknown), (unknown), (unknown), Han‐Suk Kim, (unknown), (unknown), Tatsuya Arai, SOICHIRO TODA	2
6	Eurystatins A and B, new prolyl endopeptidase inhibitors. III. Fermentation and controlled biosynthesis of eurystatin analogs by Streptomyces eurythermus. 1994 ·The Journal of Antibiotics ·Kiyoshi Suzuki, SOICHIRO TODA, TAMOTSU FURUMAI, YASUO FUKAGAWA, TOSHIKAZU OKI	6
7	A new neuritogenetic compound BU-4514N produced. 1993 ·The Journal of Antibiotics ·SOICHIRO TODA, Satoshi Yamamoto, Osamu Tenmyo, Takashi Tsuno, Toshifumi Hasegawa, (unknown), MASAHISA OKA, YOSUKE SAWADA, MASATAKA KONISHI, TOSHIKAZU OKI	15
8	Studies on the mode of antifungal action of pradimicin antibiotics. II. D-mannopyranoside-binding site and calcium-binding site. 1993 ·The Journal of Antibiotics ·Tomokazu Ueki, Kei-Ichi Numata, YOSUKE SAWADA, MAKI NISHIO, HIROAKI OHKUMA, SOICHIRO TODA, Hajime Kamachi, YASUO FUKAGAWA, TOSHIKAZU OKI	42
9	Verucopeptin, a new antitumor antibiotic active against B16 melanoma. II. Structure determination. 1993 ·The Journal of Antibiotics ·Koko Sugawara, SOICHIRO TODA, (unknown), MASATAKA KONISHI, TOSHIKAZU OKI	29
10	Epoxomicin, a new antitumor agent of microbial origin. 1992 ·The Journal of Antibiotics ·Minoru Hanada, Koko Sugawara, (unknown), SOICHIRO TODA, Yuji Nishiyama, Koji Tomita, Haruaki Yamamoto, MASATAKA KONISHI, TOSHIKAZU OKI	169
11	Eurystatins A and B, new prolyl endopeptidase inhibitors. II. Physico-chemical properties and structure determination. 1992 ·The Journal of Antibiotics ·SOICHIRO TODA, (unknown), Takashi Tsuno, Yukio Narita, (unknown), MASATAKA KONISHI	25
12	Eurystatins A and B, new prolyl endopeptidase inhibitors. I. Taxonomy, production, isolation and biological activities. 1992 ·The Journal of Antibiotics ·SOICHIRO TODA, (unknown), Kei-Ichi Numata, Yasutaro Hamagishi, Koji Tomita, (unknown), (unknown), TAMOTSU FURUMAI, TOSHIKAZU OKI	24
13	Lactimidomycin, a new glutarimide group antibiotic. Production, isolation, structure and biological activity. 1992 ·The Journal of Antibiotics ·Koko Sugawara, Yuji Nishiyama, SOICHIRO TODA, (unknown), Masami Hatori, (unknown), YOSUKE SAWADA, Hideo Kamei, MASATAKA KONISHI, TOSHIKAZU OKI	77
14	Quinaldopeptin, a novel antibiotic of the quinomycin family. 1990 ·The Journal of Antibiotics ·SOICHIRO TODA, Koko Sugawara, (unknown), (unknown), (unknown), Haruaki Yamamoto, MASATAKA KONISHI, TOSHIKAZU OKI	39
15	ChemInform Abstract: CHEMICAL CONVERSION OF NEOMYCIN B TO PAROMOMYCIN I AND ITS 6′′′‐OH ISOMER 1983 ·Chemischer Informationsdienst ·SOICHIRO TODA, Toshio Naito, Hiroshi Kawaguchi	1
16	Aminoglycoside antibiotics. XV. Chemical conversion of neomycin B to paromomycin I, 6'"-deamino-6'"-hydroxyneomycin B and 6'"-deamino-6'"-hydroxy-paromomycin I. 1983 ·The Journal of Antibiotics ·SOICHIRO TODA, Susumu Nakagawa, TAKAYUKI NAITÔ, Hiroshi Kawaguchi	10
17	Bu-2313, a new antibiotic complex active against anaerobes. III. Semi-synthesis of Bu-2313 A and B, and their analogs. 1980 ·The Journal of Antibiotics ·SOICHIRO TODA, Susumu Nakagawa, TAKAYUKI NAITÔ, Hiroshi Kawaguchi	14
18	Aminoglycoside antibiotics. XIII. Synthesis and activity of 4'-deoxy-6'-N-methylamikacin and related compounds. 1979 ·The Journal of Antibiotics ·TAKAYUKI NAITÔ, Susumu Nakagawa, SOICHIRO TODA, Kei-Ichi Fujisawa, Hiroshi Kawaguchi	7
19	Carbon-13 NMR analysis of amikacin and related compounds 1978 ·Tetrahedron Letters ·SOICHIRO TODA, Susumu Nakagawa, TAKAYUKI NAITÔ, Hiroshi Kawaguchi	13
20	AMINOGLYCOSIDE ANTIBIOTICS. II. 1973 ·The Journal of Antibiotics ·TAKAYUKI NAITÔ, Susumu Nakagawa, (unknown), SOICHIRO TODA, Kei-Ichi Fujisawa, Takeo Miyaki, Hideo Koshiyama, HIROAKI OHKUMA, Hiroshi Kawaguchi	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact